Episode

The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

Podcast: Business Of Biotech
Published: Apr 20, 2026
Duration seconds: 2813
Processing state: not_requested
Canonical source: https://www.buzzsprout.com/1011661/episodes/19019921-the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw.mp3
Audio: https://www.buzzsprout.com/1011661/episodes/19019921-the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw.mp3
JSON: /v1/public/podcasts/business-of-biotech-123501/episodes/the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw
Markdown: /podcast/business-of-biotech-123501/the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw.md

Actions

POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/business-of-biotech-123501/the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, five-time public company CFO and seven-time public company board member Allan Shaw talks about why FDA decision-making feels less predictable, and how that uncertainty is reshaping clinical trial strategy, investor behavior, and the innovation ecosystem. We talk about FDA politicization concerns, modernization efforts like AI initiatives, and what biotech leaders can do to manage risk in...